Back to overview
Active
MDL No. 2973 - District of New Jersey

Elmiron Eye Damage Lawsuit

The Elmiron lawsuit involves retina damage caused by the use of Elmiron, a drug prescribed for chronic bladder conditions like interstitial cystitis (IC), leading to legal action against the manufacturer.

Last updated May 25, 2026

2 primary sources
568

ACTIVE CASES

$1M+

TOP ESTIMATE

24%

EYE DAMAGE RISK

1-4 yr*

STATUTE WINDOW

 Search

OVERVIEW

Elmiron Eye Damage Lawsuit Overview

What is Elmiron?

Elmiron (Pentosan Polysulfate Sodium) is a medication used to treat chronic bladder conditions like interstitial cystitis (IC).

Eye Damage Link

Long-term use of Elmiron has been linked to eye damage, including pigmentary maculopathy, vision loss, and other impairments.

Liability of Manufacturer

Product liability claims allege that the manufacturer failed to warn patients and doctors about the risk of eye damage from long-term use.

Who is eligible?

If you used Elmiron for at least 6 months and were diagnosed with eye conditions like pigmentary maculopathy, you may be eligible.

CLAIMS IN AMERICA

The Complete Elmiron Eye Damage Lawsuit Guide

2026 EDITION

FREE PDF • 47 PAGES

The Complete Elmiron Eye Damage Lawsuit Lawsuit Guide

Everything you need to know about the Elmiron litigation, including reported risks and how claims are being evaluated in U.S. courts.

Case background and medical evidence
Understanding the legal process
Important medical records and timelines
What evidence strengthens your case
No sign-up required
Search

LITIGATION PROGRESS

Timeline of Elmiron Eye Damage Lawsuit

April 2026

Federal MDLs have decreased significantly from a peak of around 2,000 lawsuits to approximately 600 this month, indicating rapid settlement progress.

2025

The number of MDL cases is declining, signaling faster settlements between the parties.

2024

The Philadelphia MDL is nearing its conclusion, with the majority of cases being resolved through private agreements.

 Search

Estimated Payout

What Influences Your Claim

1

Reported Injury

The type of injury reported, such as pigmentary maculopathy, swelling in the macula, retinal damage, blind spots, and other vision-related issues, will influence the claim.

2

Medical Records

Medical diagnosis reports, scans, treatment history, and other related medical records are crucial for supporting the claim.

3

Evidence of Using Elmiron

Evidence of Elmiron use, including doctor prescriptions, pharmacy receipts, and related documentation, is essential to establish the connection between the drug and the reported injury.

*Claim outcomes depend on diagnosis, timing, and medical records. Similar cases may be valued differently based on each person’s circumstances.

Diagnostic Resources

Find a lab nearby

Locate certified MRI and neurology imaging centers to obtain the diagnostic records needed to support your claim.

Filter:
0 results near Chicago
sorted by distance
check

What to request : Ask for a contrast-enhanced brain MRI specifically looking for meningioma. Request both the radiologist's report and the imaging CD both are needed for your legal claim.

 Search

The process

How it works

From submission to attorney match, every case follows the same four-step review.

01
2 min

Submit your case

Provide basic details about Elimiron use and diagnosis.

02
2 hours

Initial review

A specialist reviews your submission and checks eligibility.

03
24 hours

Case manager call

You may be contacted to discuss medical history and records.

04
72 hours

Attorney match

If eligible, your case may be referred to a lawyer handling similar claim.

Free Case Evaluation

Check your eligibility today.

Estimated Range

$1M+

Start now
Free, no obligation
100% confidential
Takes ~3 minutes

Quick Facts

Defendant
Janssen Pharmaceuticals
Drug
Pentosan Polysulfate Sodium
Court
District of New Jersey
MDL
2973
Cases filed
568
Status
active

On This Page

Start now